| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 136,168 | 101,545 | 69,833 | | Cost of Revenue | 25,331 | 16,258 | 9,588 | | | Gross Profit | 110,837 | 85,287 | 60,245 | | | Operating Expenses | | Research Development | 22,537 | 19,762 | 14,535 | | Selling General and Administrative | 76,557 | 66,875 | 46,040 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 11,743 | (1,350) | (330) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 734 | 472 | 462 | | Earnings Before Interest And Taxes | 12,477 | (878) | 132 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 12,477 | (878) | 132 | | Income Tax Expense | 2,564 | 1,131 | 389 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,913 | (2,009) | (257) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 9,913 | (2,009) | (257) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,913 | ($2,009) | ($257) |
|
0.29% Nasdaq 
Income Statement
